Bernadette Chirac, president of the Claude Pompidou Foundation, will present the Claude Pompidou Prize for research on Alzheimer’s disease to Dr. Frédéric Checler and his team from the Institute of Molecular and Cellular Pharmacology at the University of Nice-Sophia Antipolis, this Friday, September 12.
By awarding the Prize a week before World Alzheimer’s Day (September 21) and within the Claude Pompidou Institute itself, entirely dedicated to this pathology, the Claude Pompidou Foundation reaffirms its full commitment to the fight against this terrible disease.
Dr. Checler’s team, by improving the understanding of enzymes that produce the amyloid peptide, seeks to develop drugs capable of reducing their activity without drastic side effects and to neutralize the excessive amyloid peptide produced during the pathology.
This prize, amounting to 100,000 euros, will enable the acquisition of highly efficient equipment.
The Claude Pompidou Prize was created in 2010, following the bequest of a generous donor in favor of the Claude Pompidou Foundation and allocated to research on the disease. With an annual endowment of 100,000 euros in 2014, this prize allows research teams to acquire cutting-edge technological equipment, which is often very costly yet essential for research.
